Tech Company Financing Transactions
Repairogen Funding Round
Repairogen closed a $76 thousand investment round on 3/31/2015. Investors included Partnership for New York City Fund .
Transaction Overview
Company Name
Announced On
3/31/2015
Transaction Type
Venture Equity
Amount
$76,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Consumer
Mailing Address
526 Campus Rd. 406 Weill Hall
Ithaca, NY 14853
USA
Ithaca, NY 14853
USA
Phone
Undisclosed
Website
Email Address
Overview
Repairogen uses a patent-pending DNA-repair technology to deliver the most advanced, scientifically proven, skincare and anti-aging cosmetics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Frank Borchetta
Chief Medical Officer
Gilly Munavalli
Chief Scientific Officer
Michael Boice
Browse more venture capital transactions:
Prev: 3/31/2015: Safe Deposit Box Insurance Coverage venture capital transaction
Next: 3/31/2015: Synergis Education venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs